+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Diphtheria Drug"

Diphtheria - Pipeline Insight, 2024 - Product Thumbnail Image

Diphtheria - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Diphtheria - Epidemiology Forecast - 2032 - Product Thumbnail Image

Diphtheria - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Diphtheria - Pipeline Review, H2 2020 - Product Thumbnail Image

Diphtheria - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 85 Pages
  • Global
From
  • 6 Results (Page 1 of 1)
Loading Indicator

Diphtheria is an infectious disease caused by the bacterium Corynebacterium diphtheriae. Treatment of diphtheria is primarily achieved through the administration of antibiotics, such as penicillin, erythromycin, and cephalosporins. Vaccination is also an important part of prevention and control of the disease. The diphtheria drug market is a segment of the infectious diseases drugs market. It is composed of a range of products, including antibiotics, vaccines, and other treatments. These products are used to treat and prevent diphtheria, as well as to reduce the risk of complications associated with the disease. The diphtheria drug market is highly competitive, with a number of companies offering products for the treatment and prevention of diphtheria. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more